yttrium has been researched along with Carcinoma, Hepatocellular in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 14 (93.33) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Aliseda, D; Benito, A; Bilbao, JI; Ciria, R; Hidalgo, F; Iñarrairaegui, M; Lopez-Olaondo, L; Martí-Cruchaga, P; Pardo, F; Rodríguez-Fraile, M; Rotellar, F; Sangro, B; Zozaya, G | 1 |
| Goh, BKP | 1 |
| Arepally, A; Stein, LL; Tully, MC | 1 |
| Ettorre, GM; Levi Sandri, GB; Vennarecci, G | 1 |
| Kaseb, AO | 1 |
| Bockisch, A; Ertle, J; Gerken, G; Lauenstein, T; Mueller, S; Schlaak, JF; Weng, Z; Yang, D; Zheng, S | 1 |
| Bulla, K; Kolligs, F; Malfertheiner, P; Peck-Radosavljevic, M; Reimer, P; Ricke, J; Sangro, B; Schott, E; Schütte, K; Verslype, C; Walecki, J | 1 |
| Abdella, H; Barakat, E; Bockisch, A; Dechêne, A; El Dorry, A; El Fouly, A; Ertle, J; Gerken, G; Lauenstein, T; Mueller, S; Schlaak, JF; Shaker, MK | 1 |
| Gabr, A; Kallini, JR; Lewandowski, RJ; Salem, R | 1 |
| Burak, KW; Thomas, MB; Zhu, AX | 1 |
| Abou-Alfa, GK; Geschwind, JF; Krishnan, S; Salem, R; Schwarz, RE; Venook, AP | 1 |
| Arbizu, J; Bilbao, JI; D'Avola, D; Iñarrairaegui, M; Martinez-Cuesta, A; Rodriguez, M; Sangro, B; Thurston, KG | 1 |
| Gaba, RC; Ibrahim, SM; Lewandowski, RJ; Omary, RA; Riaz, A; Ryu, RK; Salem, R; Sato, KT | 1 |
| Goh, SW; Kao, YH; Lim, KY; Ng, CE; Tan, EH | 1 |
| Mamawan, MD; Ong, SC; Senupe, JM | 1 |
1 review(s) available for yttrium and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma.
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Disease Management; Embolization, Therapeutic; Humans; Liver Neoplasms; Neoplasm Staging; Treatment Outcome; Yttrium; Yttrium Radioisotopes | 2016 |
2 trial(s) available for yttrium and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Safety and toxicity of radioembolization plus Sorafenib in advanced hepatocellular carcinoma: analysis of the European multicentre trial SORAMIC.
Topics: Carcinoma, Hepatocellular; Combined Modality Therapy; Embolization, Therapeutic; Europe; Follow-Up Studies; Liver Neoplasms; Microspheres; Niacinamide; Phenylurea Compounds; Portal Vein; Sorafenib; Treatment Outcome; Yttrium | 2015 |
In intermediate stage hepatocellular carcinoma: radioembolization with yttrium 90 or chemoembolization?
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Doxorubicin; Follow-Up Studies; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Microspheres; Prospective Studies; Survival Rate; Yttrium | 2015 |
12 other study(ies) available for yttrium and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Pure laparoscopic major liver resection after yttrium
Topics: Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Carcinoma, Hepatocellular; Feasibility Studies; Hepatectomy; Humans; Laparoscopy; Length of Stay; Liver Neoplasms; Postoperative Complications; Retrospective Studies; Yttrium | 2022 |
Yttrium-90 Radioembolization for Hepatocellular Carcinoma Prior to Liver Transplantation.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Radiopharmaceuticals; Treatment Outcome; Yttrium; Yttrium Radioisotopes | 2017 |
Transarterial Chemoembolization vs Yttrium-90 Transarterial Radioembolization.
Topics: Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Embolization, Therapeutic; Liver Neoplasms; Treatment Outcome; Yttrium; Yttrium Radioisotopes | 2017 |
Yttrium-90 Radioembolization for Hepatocellular Carcinoma Prior to Liver Transplantation: Reply.
Topics: Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Liver Neoplasms; Liver Transplantation; Radiopharmaceuticals; Treatment Outcome; Yttrium; Yttrium Radioisotopes | 2017 |
Grant, deny, or reassess the role of yttrium-90 in hepatocellular carcinoma?
Topics: Carcinoma, Hepatocellular; Humans; Liver Neoplasms; Microspheres; Radiopharmaceuticals; Treatment Outcome; Yttrium; Yttrium Radioisotopes | 2017 |
A new model to estimate prognosis in patients with hepatocellular carcinoma after Yttrium-90 radioembolization.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Hepatocellular; End Stage Liver Disease; Female; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Male; Middle Aged; Proportional Hazards Models; Radiography; Young Adult; Yttrium | 2013 |
Nonoperative therapies for combined modality treatment of hepatocellular cancer: expert consensus conference.
Topics: Antineoplastic Agents; Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Consensus Development Conferences as Topic; Hepatectomy; Humans; Liver Neoplasms; Liver Transplantation; Neoplasm Staging; Niacinamide; Patient Selection; Phenylurea Compounds; Practice Guidelines as Topic; Protein Kinase Inhibitors; Pyridines; Radiopharmaceuticals; Radiotherapy; Sorafenib; Treatment Outcome; Yttrium | 2010 |
Nonoperative therapies for combined modality treatment of hepatocellular cancer: expert consensus statement.
Topics: Antineoplastic Agents; Benzenesulfonates; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Hepatectomy; Humans; Liver Neoplasms; Liver Transplantation; Neoplasm Staging; Niacinamide; Patient Selection; Phenylurea Compounds; Protein Kinase Inhibitors; Pyridines; Radiopharmaceuticals; Radiotherapy; Sorafenib; Treatment Outcome; Yttrium | 2010 |
Radioembolization with use of yttrium-90 resin microspheres in patients with hepatocellular carcinoma and portal vein thrombosis.
Topics: Aged; Carcinoma, Hepatocellular; Embolization, Therapeutic; Female; Humans; Kaplan-Meier Estimate; Liver Neoplasms; Magnetic Resonance Imaging; Male; Microspheres; Middle Aged; Neoplasm Staging; Portal Vein; Radiopharmaceuticals; Retrospective Studies; Spain; Time Factors; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Treatment Outcome; Venous Thrombosis; Yttrium | 2010 |
Safety of yttrium-90 microsphere radioembolization in patients with biliary obstruction.
Topics: Aged; Aged, 80 and over; Alkaline Phosphatase; Bilirubin; Biomarkers; Carcinoma, Hepatocellular; Chicago; Cholestasis; Embolization, Therapeutic; Female; Humans; Leukocyte Count; Liver Neoplasms; Magnetic Resonance Imaging; Male; Microspheres; Middle Aged; Neoplasm Staging; Radiopharmaceuticals; Retrospective Studies; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Yttrium | 2010 |
Yttrium-90 internal pair production imaging using first generation PET/CT provides high-resolution images for qualitative diagnostic purposes.
Topics: Carcinoma, Hepatocellular; Catheter Ablation; Female; Humans; Liver Neoplasms; Microspheres; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Quality Control; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Yttrium | 2012 |
Post-90Y radioembolization PET/CT scan with respiratory gating using time-of-flight reconstruction.
Topics: Aged; Carcinoma, Hepatocellular; Embolization, Therapeutic; Humans; Image Processing, Computer-Assisted; Liver Neoplasms; Male; Multimodal Imaging; Positron-Emission Tomography; Respiratory-Gated Imaging Techniques; Time Factors; Tomography, X-Ray Computed; Yttrium | 2013 |